miRNA-192-5p impacts the sensitivity of breast cancer cells to doxorubicin via targeting peptidylprolyl isomerase A
published in: Kaohsiung Journal of Medical Sciences
date of publication: 2019-01-01
main subject: doxorubicin
Cites articles
There is nothing here
Article - wd:Q92190650